Phase III trial of high-dose cyclophosphamide in patients with multiple sclerosis

Trial Profile

Phase III trial of high-dose cyclophosphamide in patients with multiple sclerosis

Planning
Phase of Trial: Phase III

Latest Information Update: 09 May 2012

At a glance

  • Drugs Cyclophosphamide (Primary)
  • Indications Multiple sclerosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Accentia Biopharmaceuticals
  • Most Recent Events

    • 09 May 2012 Plans for this trial presented to potential investigators, according to an Accentia Biopharmaceuticals media release.
    • 02 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top